Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Genovese

Showing results (61-70 of 172) with videos related to

Pageof 18
Sort By:
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|August 14, 2012
Effects of sclerostin antibody on healing of a non-critical size femoral bone defectMuhammad U Jawad, Kate E Fritton, Ting Ma, et al.
The Journal of Rheumatology|August 17, 2017
Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid ArthritisEdward C Keystone, Mark C Genovese, Douglas E Schlichting, et al.
Arthritis and Rheumatism|February 1, 2011
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agentsMark C Genovese, Arthur Kavanaugh, Michael E Weinblatt, et al.
The Lancet. Rheumatology|January 26, 2024
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot studyMark C Genovese, Norman B Gaylis, David Sikes, et al.
Rheumatology (Oxford, England)|July 20, 2023
A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosisMatthew C Baker, Audra Horomanski, Yiwen Wang, et al.
Annals of the Rheumatic Diseases|January 10, 2013
Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammationBruce W Kirkham, Mary Chester Wasko, Elizabeth C Hsia, et al.
The Journal of Rheumatology|May 17, 2013
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results through 2 years of the GO-FORWARD study extensionEdward C Keystone, Mark C Genovese, Stephen Hall, et al.
Arthritis Care & Research|July 25, 2015
Reliability and Validity of the Psoriasis Symptom Inventory in Patients With Psoriatic ArthritisHilary D Wilson, Alex Mutebi, Dennis A Revicki, et al.
The Journal of Rheumatology|December 7, 2005
A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosisMark C Genovese, Eliza F Chakravarty, David L Boyle, et al.
Drugs & Aging|March 16, 2006
Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studiesMichael H Schiff, Elaine B Yu, Michael E Weinblatt, et al.
Pageof 18

Showing results (61-70 of 172) with videos related to

Sort By:
Pageof 18
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|August 14, 2012
Effects of sclerostin antibody on healing of a non-critical size femoral bone defectMuhammad U Jawad, Kate E Fritton, Ting Ma, et al.
The Journal of Rheumatology|August 17, 2017
Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid ArthritisEdward C Keystone, Mark C Genovese, Douglas E Schlichting, et al.
Arthritis and Rheumatism|February 1, 2011
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agentsMark C Genovese, Arthur Kavanaugh, Michael E Weinblatt, et al.
The Lancet. Rheumatology|January 26, 2024
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot studyMark C Genovese, Norman B Gaylis, David Sikes, et al.
Rheumatology (Oxford, England)|July 20, 2023
A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosisMatthew C Baker, Audra Horomanski, Yiwen Wang, et al.
Annals of the Rheumatic Diseases|January 10, 2013
Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammationBruce W Kirkham, Mary Chester Wasko, Elizabeth C Hsia, et al.
The Journal of Rheumatology|May 17, 2013
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results through 2 years of the GO-FORWARD study extensionEdward C Keystone, Mark C Genovese, Stephen Hall, et al.
Arthritis Care & Research|July 25, 2015
Reliability and Validity of the Psoriasis Symptom Inventory in Patients With Psoriatic ArthritisHilary D Wilson, Alex Mutebi, Dennis A Revicki, et al.
The Journal of Rheumatology|December 7, 2005
A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosisMark C Genovese, Eliza F Chakravarty, David L Boyle, et al.
Drugs & Aging|March 16, 2006
Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studiesMichael H Schiff, Elaine B Yu, Michael E Weinblatt, et al.
Pageof 18